|
|
 |
|
Our current portfolio consists of investments in the following startup companies:
|
|
 | Bioprocess Control AB - Lund, Sweden |
|
Bioprocess Control provides technologies and services that support the efficient design and operation of biogas plants & processes.
|
|
 | Ganeden Biotech Inc. - Mayfield Heights, Ohio, USA |
|
Ganeden Biotech Inc. is a US probiotics company which markets supplements focused on digestive health.
|
|
 | Harland Medical Systems, Inc. - Eden Prairie, Minnesota, USA |
|
Harland offers complete coating solutions to medical device customers through integration of automated equipment platforms, application services and coating formulations.
|
|
 | Inmat Inc. - Hillsborough, New Jersey, USA |
|
InMat Inc. develops and commercializes flexible nanocomposite barrier coatings, to be used among others in the tire and packaging industry.
|
|
 | IntegraGen SA - Evry, France |
|
IntegraGen is dedicated to discovering genes associated with complex diseases and commercializing molecular diagnostic tests to enable personalized healthcare.
|
|
 | IQ Therapeutics B.V. - Groningen, The Netherlands |
|
IQ Therapeutics is a Dutch company developing human antibodies for the prevention and treatment of infectious diseases.
|
|
 | Novomer, Inc. - Ithaca, NY, USA |
|
Novomer develops a technology platform to use carbon dioxide and other renewable materials to produce performance polymers, plastics and other chemicals.
|
|
 | Provexis plc - London, United Kingdom |
|
Provexis discovers, develops and licenses scientifically-proven technologies for the global functional food, medical food and dietary supplement sectors.
|
|
 | Segetis, Inc. - Golden Valley, Minnesota, USA |
|
Segetis, Inc. produces and sells sustainable performance materials using proprietary renewable chemistry routes and based on non-food agricultural and forestry feedstock.
|
|
 | Sol-Gel Technologies Ltd. - Bet Shemesh, Israel |
|
Sol-Gel develops innovative specialty pharmaceuticals for the dermatology market, targeting improved efficacy, tolerability and safety of topical drugs with proprietary delivery systems.
|
|
 | Suprapolix B.V., - Eindhoven, The Netherlands |
|
SupraPolix B.V. develops a supramolecular chemistry platform based on quadruple hydrogen bonds aiming at applications in consumer and industry markets.
|
|
 | Tianjin Green Bio-Science Co. Ltd. - Tianjin, China |
|
Tianjin Green Bio-Science is a Chinese company dedicated to developing and producing biodegradable polymers and products.
|
|
 | Upfront Chromatography A/S - Copenhagen, Denmark |
|
Upfront Chromatography A/S develops and manufactures innovative products and technologies for extraction and recovery of biotherapeutics, functional biomolecules, macromolecular complexes, and even living cells, directly from bioreactors and industrial side-streams.
|
|
 | Van Technologies Inc. - Duluth, MN, USA |
|
Van Technologies develops and markets innovative performance coating solutions using technologies that are environmentally responsible.
|
|
 | Viocare, Inc. - Princeton, NJ, USA |
|
Viocare develops sophisticated web-based technologies that analyze dietary and physical activity behavior to generate personalized lifestyle plans for patients and consumers.
|
|
 | Xylos Corporation - Langhorne, PA, USA |
|
Xylos Corporation is active in healthcare products based on biosynthesized cellulose. Application areas are advanced wound dressings, surgical repair products and tissue engineering.
|
|
| |
